Skip to main content

Peer Review reports

From: GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer

Original Submission
25 Mar 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
16 Jun 2010 Author responded Author comments - Rolf Brekken
26 Apr 2010 Reviewed Reviewer Report - Nikki Cheng
1 May 2010 Reviewed Reviewer Report - Bjorn Olsen
Resubmission - Version 3
16 Jun 2010 Submitted Manuscript version 3
28 Jul 2010 Author responded Author comments - Rolf Brekken
2 Jul 2010 Reviewed Reviewer Report - Nikki Cheng
1 Jul 2010 Reviewed Reviewer Report - Bjorn Olsen
Resubmission - Version 4
28 Jul 2010 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
29 Jul 2010 Author responded Author comments - Rolf Brekken
Resubmission - Version 6
29 Jul 2010 Submitted Manuscript version 6
Publishing
30 Jul 2010 Editorially accepted
30 Jul 2010 Article published 10.1186/1471-2407-10-397

You can find further information about peer review here.

Back to article page